TRIM38 has been shown to be capable of activating NF-κB signaling pathways (31) and may participate in regulating innate immune response, various pathophysiological processes, such as bone proliferation, tumorigenesis, and autoimmune diseases (10, 13). The gene discussed is TRIM38; the disease is autoimmune disease.